Clinical equipoise remains for issues of adrenocorticotropic hormone administration, cortisol testing, and therapeutic use of hydrocortisone [3]

Critical Care Medicine

Volumn 31, Issue 8, 2003, Pages 2250-2251

  Annane, Djillali ^a   Briegel, Josef ^b   Keh, Didier ^c   Moreno, Rui ^d   Singer, Mervyn ^e   Sprung, Charles L ^f  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY OF MUNICH   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d Hopsital de Curry Cabral   (Portugal)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BOLDENONE UNDECENOATE; CORTICOTROPIN; HYDROCORTISONE;

ADRENAL CORTEX FUNCTION; ADRENAL INSUFFICIENCY; CORTICOSTEROID THERAPY; DRUG USE; LETTER; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0041942666     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000080485.75448.45     Document Type: Letter

References (11)

1. Marik PE, Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med 2003; 31:141-145
2. Sprung CL, Caralis PV, Marcial EH, et al: The effect of high-dose corticosteroids in patients with septic shock: A prospective, controlled study. N Engl J Med 1984; 311:1137-1143
3. The Veterans Administration Systemic Sepsis Cooperative Study Group: Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987; 317:659-665
4. Briegel J, Forst H, Haller M, et al: Contribution of cortisol deficiency to septic shock. Lancet 1991; 338:507-508
5. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single center study. Crit Care Med 1999; 27:723-732
6. Schein RMH, Sprung CL, Marcial EH, et al: Plasma cortisol levels in patients with septic shock. Crit Care Med 1990; 18:259-263
7. Annane D, Bellissant E, Sebille V, et al: Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998; 46:589-597
8. Matot I, Sprung CL: Corticosteroids in septic shock: Resurrection of the last rites? Crit Care Med 1998; 26:627-630
9. Annane D, Sebille V, Troche G, et al: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045
10. Annane D, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-870
11. Keh D, Boehnke T, Weber-Cartens S, et al: Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: A double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003; 167:512-520